1-TERT-BUTYL 4-ETHYL 4-BENZYLPIPERIDINE-1,4-DICARBOXYLATE, 95.0%, 1g

(2,6-Dichloro-5-fluoropyridin-3-yl)methanamine, 96%, 1g

2-Oxa-7-azaspiro[4.4]nonane hemioxalate, 98%, 250mg

Potassium (ethoxymethyl)trifluoroborate, 97%, 5g

Isoquinoline-4-carboxylic acid, 95.0%, 5g

4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-DIHYDROXY-10,13-DIMETHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL)-2-OXOETHOXY)-4-OXOBUTANOIC ACID, 95%, 1g

2-[(Cyanomethyl)thio]-4-(methoxymethyl)-6-methylnicotinonitrile, 95.0%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosylpiperidine, 95%, 5g

2-(Bromomethyl)-1-methoxy-4-nitrobenzene, 95.0%, 250mg

1,1-Cyclohexanediacetic acidanhydride, 95.0%, 50g

3-((4-FLUOROPHENOXY)METHYL)PYRROLIDINE HCL, 97.0%, 250mg

Antimon-Target 99,999 % Durchmesser. 25,4 mm x Stärke 6,35 mm 1 Stk

(3,5-Diphenyl-pyrazol-1-yl)-acetic acid, 5g